We used bacteria-derived bovine alpha-interferon Il (Bo to study its antiviral effect in a bovine turbinate cell line on bovine diarrhea virus, infectious bovine rhinotracheitis virus, parainfluenza 3 virus, and pseudorabies virus. We based our study upon replicate tests for each strain by using a block titration system with various concentrations of Bo Few studies involving interferon have dealt with in vitro interferon production by bovine tissues or cells or both and its effect on cattle viruses. Fulton and Rosenquist (2) induced in vivo interferon production in bovine tissues with infectious bovine rhinotracheitis virus (IBR) and found that the highest concentrations were produced by bovine fetal spleen cell cultures and alveolar macrophage cultures derived from adult cattle. Trueblood and Manjara (4) infected bovine embryo, kidney, and chicken embryo fibroblast cultures with various bovine viruses and found the induction of an inhibitory substance with characteristics attributable to interferon. In the present study, bacteria-derived bovine alpha interferon Il (Bo IFN-a1l) was studied for its protective capacity against selected bovine viruses in a cell culture system.
Few studies involving interferon have dealt with in vitro interferon production by bovine tissues or cells or both and its effect on cattle viruses. Fulton and Rosenquist (2) induced in vivo interferon production in bovine tissues with infectious bovine rhinotracheitis virus (IBR) and found that the highest concentrations were produced by bovine fetal spleen cell cultures and alveolar macrophage cultures derived from adult cattle. Trueblood and Manjara (4) infected bovine embryo, kidney, and chicken embryo fibroblast cultures with various bovine viruses and found the induction of an inhibitory substance with characteristics attributable to interferon. In the present study, bacteria-derived bovine alpha interferon Il (Bo IFN-a1l) was studied for its protec- tive capacity against selected bovine viruses in a cell culture system.
MATERIALS AND METHODS
Source of bacteria-derived Bo IFN-acl. Bo IFN-al, was synthesized in Escherichia coli (3) (Fig. 2) ; any response increment which exceeds this difference is statistically significant at the 5% level. One exception occurred where this statistical approach could provide only a lower-bound estimate of the PD50; in the case of BVD-NADL virus, the highest Bo IFN-al1 dose produced complete protection at all six virus dose levels in every experiment.
RESULTS
Graphic interpretation of data. The in vitro protective effect of bacteria-derived Bo IFN-aol against two strains of B3VD virus, two strains of IBR virus, one strain of PR virus, and the SF4 strain of bovine PI3 virus is presented in Fig. 2 .
There was an obvious dose-protective Bo IFN-a1, response in the cell culture trials against all virus strains.
As evidenced in replicate tests, the Singer (r = 4) and NADL (r = 6) strains of BVD virus were equally and markedly susceptible to Bo IFN-a1, in the bovine turbinate cell culture system. There was some biological activity against these two strains at a concentration of 10 U/ml with approximately log 101 TCID50 of the NADL strain and log 102 TCID50 of the Singer strain being inactivated. With 10-fold increases of Bo IFN-ail, a corresponding amount of virus was inactivated. The greatest activity occurred at a Bo IFN-ao1 concentration of 104 U/ml with inactivation of log 105.2 TCID50 of the Singer strain and log 106 TCID50 of the NADL strain.
Bo IFN-ao1 had a progressive protective effect against PR virus as demonstrated in six replicate tests. At a concentration of 10 U/ml, approximately log 101-6 TCID50 of virus was inactivated. At concentrations of 102 and 103 U/ml, there was a slight increase in viral inactivity, and at 104 U/ml, approximately log 10.325 TCID50 of virus was inactivated.
Bo IFN-ao1 also showed biological activity against the SF strain of PI3 virus. The order of viral inactivity in six replicate tests was in essence 1 log lower than that observed with PR virus, as a Bo IFN-a1l concentration of 104 U/ml inhibited slightly more than 2 log of PI3 virus.
The Bo IFN-ao1 had the least inhibitory effect on two strains of IBR virus at Bo IFN-al levels of 104 U/ml. In seven replicate tests with the Cornell strain, 104 U of Bo IFN-a1, per ml inhibited slightly more than 1 log of virus. In three replicate tests with the Cooper strain, the same con--against selected bovine viruses. r = number of replicate tests. I Standard error f2: nonoverlapping intervals of a response curve indicate statistically significant differences. 
DISCUSSION
The availability of purified preparations of bacteriaderived bovine interferons affords investigators an opportunity to study the effects of various classes of bovine interferon produced by recombinant technology both in vitro and in vivo. The production of appreciable amounts of highly concentrated, relatively pure, stable interferons has permitted investigators to design experiments heretofore impossible.
In our search of the literature, we were unable to locate any study where bacteria-derived Bo IFN-a11 was tested for its in vitro protective effect against various bovine viruses. The use of the block titration configuration with appropriate virus and cell controls in a sufficient number of replicate tests provided an excellent method to analyze the data by statistical means. Although it is common practice to pretreat cell cultures with interferon overnight, we decided to analyze protection against bovine viruses by pretreatment with Bo IFN-atl followed immediately by introduction of virus.
As the data indicate, there was marked viral inhibition against two strains of BVD virus; thus, it is a sensitive test procedure. There was no evidence of additive protection by interference when Bo IFN-axl was introduced into our system 2 h in advance of BVD, IBR, or P13 viruses.
In the case of two economically important viruses, BVD and IBR, two different strains were employed in the tests. Although the Singer and Holmes strains of BVD virus cross-protect in reciprocal cattle challenge tests, there is a considerable titer difference in the reciprocal serum neutralization test. Thus, representatives of two serological groups for this virus were evaluated. The Bo IFN-atl provided a marked protective effect against each strain of BVD virus in our bovine turbinate cell culture test system. At the other end of the protective spectrum, both the Cornell and Cooper strains of IBR virus were affected only to a minor degree by the Bo IFN-a1l. Bo IFN-al1 hâd a greater protective effect against PI3 virus that was slightly greater than the observable effect on IBR virus. These in vitro experiments provide encouragement to perform experimental and field trials to evaluate the usefulness of Bo in the control of these virus diseases in cattle. It also would be interesting to combine some other bovine interferon classes with Bo IFN-a1l to ascertain whether higher levels of protection can be achieved in in vitro and in vivo experiments.
